Brewin Dolphin LTD Gilead Sciences, Inc. Transaction History

Brewin Dolphin LTD

$2.08 Billion
Q2 2022

A detailed history of Brewin Dolphin LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Brewin Dolphin LTD holds 3,547 shares of GILD stock, worth $327,778. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,547

Previous 3,547 -0.0%

Holding current value

$327,778

Previous $211,000 3.79%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Nov 14, 2022	SELL	$57.92 - $72.58 $12,626 - $15,822	-218 Reduced 5.79%	3,547 $211,000
Q4 2021 Nov 14, 2022	BUY	$64.88 - $73.64 $244,273 - $277,254	3,765 New	3,765 $273,000
Q3 2021 Nov 09, 2023	SELL	$67.69 - $73.03 $4,061 - $4,381	-60 Reduced 2.27%	2,578 $180 Million
Q2 2021 Nov 09, 2023	SELL	$63.47 - $69.35 $2,538 - $2,774	-40 Reduced 1.49%	2,638 $182 Million
Q1 2021 Nov 09, 2023	SELL	$60.0 - $68.46 $142,500 - $162,592	-2,375 Reduced 47.0%	2,678 $173 Million
Q4 2020 Nov 09, 2023	SELL	$56.65 - $64.55 $4,532 - $5,164	-80 Reduced 1.56%	5,053 $294 Million
Q3 2020 Nov 09, 2023	SELL	$62.1 - $78.08 $36,887 - $46,379	-594 Reduced 10.37%	5,133 $324 Million
Q2 2020 Nov 09, 2023	BUY	$72.34 - $84.0 $10,127 - $11,760	140 Added 2.51%	5,727 $441 Million
Q1 2020 Nov 09, 2023	BUY	$62.63 - $80.22 $80,166 - $102,681	1,280 Added 29.72%	5,587 $418 Million
Q4 2019 Nov 09, 2023	SELL	$61.62 - $67.78 $16,760 - $18,436	-272 Reduced 5.94%	4,307 $280 Million
Q3 2019 Nov 09, 2023	BUY	$62.51 - $69.0 $4,750 - $5,244	76 Added 1.69%	4,579 $290 Million
Q2 2019 Nov 09, 2023	SELL	$61.87 - $69.38 $23,201 - $26,017	-375 Reduced 7.69%	4,503 $304 Million
Q3 2018 Nov 09, 2023	SELL	$71.28 - $78.92 $482,280 - $533,972	-6,766 Reduced 58.11%	4,878 $377 Million
Q2 2018 Nov 09, 2023	SELL	$64.88 - $75.68 $36,657 - $42,759	-565 Reduced 4.63%	11,644 $825 Million
Q1 2018 Nov 09, 2023	SELL	$72.84 - $88.8 $14,568 - $17,760	-200 Reduced 1.61%	12,209 $920 Million
Q3 2017 Nov 09, 2023	BUY	$72.11 - $85.47 $639,038 - $757,435	8,862	12,409 $1.01 Billion

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Account

Brewin Dolphin LTD Gilead Sciences, Inc. Transaction History